TGR5-mediated bile acid sensing controls glucose homeostasis.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cell Metabolism

• Publication date

  2009-09-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cmet.2009.08.001PMID 19723493PMCID PMC2739652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism

  2009cited by this paper
• Targeting bile-acid signalling for metabolic diseases

  2008cited by this paper
• FXR signaling in metabolic disease

  2008cited by this paper
• Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity

  2008cited by this paper
• Dietary Manipulation of Mouse Metabolism

  2008cited by this paper
• Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.

  2008cited by this paper
• Molecular Field Analysis and 3D-Quantitative Structure-Activity Relationship Study (MFA 3D-QSAR) Unveil Novel Features of Bile Acid Recognition at TGR5

  2008cited by this paper
• Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation.

  2008cited by this paper
• Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion

  2008cited by this paper
• Glucose Sensing in L Cells: A Primary Cell Study

  2008influential reference
• Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5.

  2007cited by this paper
• Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.

  2007cited by this paper
• Compromised Intestinal Lipid Absorption in Mice with a Liver-Specific Deficiency of Liver Receptor Homolog 1

  2007cited by this paper
• Histopathology in Mouse Metabolic Investigations

  2007cited by this paper
• Evaluation of Glucose Homeostasis

  2007cited by this paper
• A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.

  2007cited by this paper
• The biology of incretin hormones.

  2006influential reference
• Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents.

  2006cited by this paper
• Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

  2006cited by this paper
• Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells.

  2006cited by this paper
• The role of voltage-gated calcium channels in pancreatic beta-cell physiology and pathophysiology.

  2006cited by this paper
• KATP channels as molecular sensors of cellular metabolism

  2006cited by this paper
• Abdominal obesity and metabolic syndrome

  2006cited by this paper
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

  2006influential reference
• Farnesoid X receptor is essential for normal glucose homeostasis.

  2006influential reference
• Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.

  2006influential reference
• Evaluation of Energy Homeostasis

  2006cited by this paper
• Minimizing Variation Due to Genotype and Environment

  2006cited by this paper
• Endocrine functions of bile acids

  2006cited by this paper
• Collection of Blood and Plasma from the Mouse

  2006cited by this paper
• Lipid and Bile Acid Analysis

  2006cited by this paper
• Characterization and functional role of voltage gated cation conductances in the glucagon‐like peptide‐1 secreting GLUTag cell line

  2005cited by this paper
• Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.

  2005cited by this paper
• The Farnesoid X Receptor Modulates Hepatic Carbohydrate Metabolism during the Fasting-Refeeding Transition*

  2005influential reference
• Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

  2005influential reference
• Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120

  2005cited by this paper
• Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.

  2004cited by this paper
• Intestinal Epithelial Cells Synthesize Glucocorticoids and Regulate T Cell Activation

  2004cited by this paper
• Impaired pancreatic growth, beta cell mass, and beta cell function in E2F1 (-/- )mice.

  2004cited by this paper
• Impaired pancreatic growth, β cell mass, and β cell function in E2F1 –/– mice

  2004cited by this paper
• A G Protein-coupled Receptor Responsive to Bile Acids*

  2003influential reference
• Glucose-sensing in glucagon-like peptide-1-secreting cells.

  2002cited by this paper
• Identification of membrane-type receptor for bile acids (M-BAR).

  2002influential reference
• Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum.

  1982cited by this paper

• Quercetin Ameliorates Glucose Metabolism Dysregulation in CUMS Model Rats via the Bile Acid-FXR/TGR5 Axis.

  2026cites this paper
• The gut–heart axis in coronary artery disease: a scoping and narrative review of sex-based microbial and metabolic disparities

  2026cites this paper
• Discovery of Obacunone as a TGR5 Agonist from Rhizoma coptidis: Affinity Screening, Functional Verification and Transcriptional Analysis.

  2026cites this paper
• Bile Acids and Healthy Ageing

  2026cites this paper
• Critical role of reproductive tract microbiota and derived metabolites in inflammation, tumor immunity, and tumorigenesis of gynecological cancers: a narrative review

  2026cites this paper
• Bile acid signaling, metabolism, and aging

  2026cites this paper
• Changes in circulating bile acid levels during cold exposure are associated with brown adipose tissue in humans: a secondary analysis from the ACTIBATE study

  2026cites this paper
• Feedback Regulation of Pancreatic Juice Secretion in Pigs.

  2026cites this paper
• Antibiotic-Mediated Modulation of the Gut Microbiome Identifies Taurine as a Modulator of Adipocyte Function Through TGR5 Signaling

  2026cites this paper
• Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities.

  2026cites this paper
• Dietary fiber enhances the intestinal profile of beneficial commensal Bacteroides acidifaciens and modulates bile acid metabolism in T2DM mice

  2026cites this paper
• Targeting the brain-gut-taste axis: The role of GLP-1-mediated SGLT-1 signaling in metabolic diseases

  2026cites this paper
• Regulation of allergies across the body by microbial metabolites.

  2026cites this paper
• Gut Microbiota-Derived Metabolites to Regulate Intramuscular Fat Deposition in Pigs.

  2026cites this paper
• The role of PYY in improving insulin resistance.

  2026cites this paper
• Targeting the gut microbiota: the application and prospects of probiotics, fecal microbiota transplantation, and natural products in MASLD

  2026cites this paper
• Integrated metabolomic and transcriptomic analyses reveal Radix Bupleuri alleviates MASLD induced by a high-fat diet and circadian disruption via the DCA/HCA-TGR5-GLP-1 axis.

  2026cites this paper
• Takeda G Protein-Coupled Receptor 5 and Peroxisome Proliferator-Activated Receptor-Gamma Activation by Pinocembrin and Pinostrobin Isolated from Lindera sericea.

  2026cites this paper
• The Collaborative Collapse: Bile Acid Dysmetabolism as a Central Pathogenic Driver in Canine and Feline Multi-Systemic Disorders-From Mechanisms to Precision Therapeutics.

  2026cites this paper
• Probiotics for managing non-alcoholic fatty liver disease: efficacy and mechanistic insights

  2026cites this paper
• Polysaccharide from Walnut Green Husk alleviates ochratoxin a-induced anorexia in chicks via m6A-mediated FXR regulation of orexigenic genes

  2026cites this paper
• Gut Microbiota–Leptin crosstalk in obesity and metabolic dysregulation

  2026cites this paper
• Dialogue between the Gut Microbiota and the Endocrine Axis: From Mechanistic Insights to a New Paradigm for Precision Medicine

  2026cites this paper
• The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors.

  2026cites this paper
• Research progress on the structure of edible fungi polysaccharides and their anti-obesity mechanisms via the regulation of intestinal microbiota and metabolites

  2026cites this paper
• Emerging Role of Taste Receptors, Entero-Endocrine Cells in Type 2 Diabetes and Metabolic Disorders

  2026cites this paper
• Dietary Fiber Regulation of Gut Microbiota and Bile Acid Metabolism in Animals: Implications for Animal Nutrition.

  2026cites this paper
• The role of bile acid-activated receptor TGR5 in inflammation and liver diseases.

  2026cites this paper
• Research Advances and Therapeutic Potential of Gut Microbiota in Metabolic Diseases

  2026cites this paper
• Exercise intervention regulates gut microbiota to improve type 2 diabetes: a narrative review of the mechanisms

  2025cites this paper
• The role of enteroendocrine cells, hormones, and gut microbiota in anorexia nervosa: a complex interplay of the microbiome-gut-brain axis

  2025cites this paper
• Evaluation of anti-obesogenic and anti-diabetic effects of tauroursodeoxycholic acid in Swiss albino rats: possible blockage of CHOP-dependent mitochondrial shuttling of TBP-2 and antagonism of streptozotocin-induced type 2 diabetes

  2025cites this paper
• Microbiota-Mediated Bile Acid Metabolism as a Mechanistic Framework for Precision Nutrition in Gastrointestinal and Metabolic Diseases

  2025cites this paper
• Bile acids regulate lipid metabolism through selective actions on fatty acid absorption.

  2025cites this paper
• Integrating bile acid metabolism into precision nutrition strategies for improved swine performance.

  2025cites this paper
• Targeted Therapy for Gut Microbiota: Candidates for a Novel Strategy to Ameliorate Type 2 Diabetes Mellitus

  2025cites this paper
• Novel bis(triazole) analogues as selective TGR5 agonists with anti-diabesity effects.

  2025cites this paper
• Diabetes mellitus and hepatosteatosis: a narrative review

  2025cites this paper
• Intestinal TGR5-targeted carrier-drug conjugate improves glycemic control in mice and pigs.

  2025cites this paper
• The Investigation into Correlation between Type 2 Diabetes Mellitus and the Gut Microbiota

  2025cites this paper
• Circulating Profiles of the Bile Acid Metabolomics in Patients With Polycystic Ovary Syndrome Treated With Metformin or Canagliflozin

  2025cites this paper
• Prebiotic dietary fibre from marine seaweed: A potential treatment strategy for type 2 diabetes

  2025cites this paper
• Multi-omics analysis reveals the mechanism of Lactobacillus plantarum in alleviating metabolic disorders in type 2 diabetic mice through the gut-liver axis

  2025cites this paper
• Potential mechanisms of natural metabolites and botanical drugs foumulae for the treatment of non-alcoholic fatty liver disease: targeting the gut microbiota to modulate the immune system

  2025cites this paper
• Bile acid signaling in MASLD: from pathogenesis to therapeutic applications.

  2025cites this paper
• Poria cocos polysaccharides as a carbon source promotes the proliferation of Parabacteroides distasonis to ameliorate ulcerative colitis: A mechanistic study based on the secondary bile acid-TGR5 axis

  2025cites this paper
• Role of intestinal SCFAs homeostasis in the hepatoprotective effect of Clostridium butyricum in T2DM

  2025cites this paper
• Advances in understanding the role of gut microbiota in fat deposition and lipid metabolism

  2025cites this paper
• Adipose TGR5 Deletion Promotes Hepatic Steatosis Through Decreasing Adiponectin Secretion in Mice

  2025cites this paper
• Metformin-mechanisms of its glycemia-reducing effect.

  2025cites this paper
• Structure-Based Insights into TGR5 Activation by Natural Compounds: Therapeutic Implications and Emerging Strategies for Obesity Management

  2025cites this paper
• Chemical recognition of phytochemicals and microbiota-derived metabolites in the gut and implication for physiological function in the body.

  2025cites this paper
• Advances in Pharmacological Activities, Biosynthesis, and Structural Modification of Ursodeoxycholic Acid (UDCA): A Review

  2025cites this paper
• Gut microbiota drives the metabolic dysregulation in obesity-prone individuals by impairing GDCA-mediated activation of brown adipose thermogenesis and ileal GLP-1 secretion

  2025cites this paper
• Hyocholic Acid Species as the Key Modulator for Cecal Epithelial Homeostasis in Low-Birth-Weight Piglets

  2025cites this paper
• The Oral–Gut Microbiota Axis Across the Lifespan: New Insights on a Forgotten Interaction

  2025cites this paper
• GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications

  2025cites this paper
• Novel Therapeutic Strategies for Obesity-Related Glomerulopathy

  2025cites this paper
• The Critical Role of the Bile Acid Receptor TGR5 in Energy Homeostasis: Insights into Physiology and Therapeutic Potential

  2025cites this paper
• Characterization of Breadfruit (Artocarpus altilis) and Its Long-Term Effect on Glucose and Lipid Metabolism in Rats Fed with a High-Fat Diet

  2025cites this paper
• Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer

  2025cites this paper
• The Role of Five‐Membered Aromatic Rings Containing N and O in Modulating Bile Acid Receptors: An Overview

  2025cites this paper
• Targeting the gut microbiota-bile acid axis: Therapeutic strategies for cholestatic liver disease and metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• Microbial Interactions with Intestinal Lipid Digestion and Absorption: Emerging Targets for Metabolic Disorders

  2025cites this paper
• Dysregulated bile acid metabolism as a novel player in gout progression: emerging therapeutic strategies

  2025cites this paper
• Fexaramine as the intestine-specific farnesoid X receptor agonist: A promising agent to treat obesity and metabolic disorders.

  2025cites this paper
• Porphyran from discolored nori prevents metabolic syndrome through microbiota-bile acid-ceramide pathway

  2025cites this paper
• Deciphering the gut microbiome’s metabolic code: pathways to bone health and novel therapeutic avenues

  2025cites this paper
• Bile acid 7α-dehydroxylating bacteria accelerate injury-induced mucosal healing in the colon

  2025influential citation
• Alterations in intestinal bile acid transport provide a therapeutic target in patients with post-bariatric hypoglycaemia

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease in adults

  2025cites this paper
• Gut–X axis

  2025cites this paper
• Gut microbiota-mediated bile acid transformations regulate the transport of aflatoxin B1 from the intestine to the liver in piglets

  2025cites this paper
• Antidiabetic constituents of kaempferiae rhizoma: previously undescribed O-linked diarylheptanoid dimers promoting GLP-1 secretion via PKA-CREB pathway.

  2025cites this paper
• Gut microbiome research: Revealing the pathological mechanisms and treatment strategies of type 2 diabetes

  2025cites this paper
• Gut microbiome links obesity to type 2 diabetes: insights from Mendelian randomization

  2025cites this paper
• The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity

  2025cites this paper
• Cyanidin-3-O-glucoside enhances GLP-1 secretion via PPARβ/δ-β-catenin-TCF-4 pathway in type 2 diabetes mellitus

  2025cites this paper
• Bile Acids and Type 2 Diabetes: Roles in Glucose Homeostasis and Therapeutic Opportunities

  2025cites this paper
• Pig bile powder maintains blood glucose homeostasis by promoting glucagon-like peptide-1 secretion via inhibiting farnesoid X receptor

  2025cites this paper
• Mechanism of TGR5 in Ferroptosis of the Renal Tubular Epithelial Cells in Diabetes Mellitus and the Effect of Notoginsenoside Ft1

  2025cites this paper
• Compositional and Metabolomic Shifts of the Gut Microbiome in Alcohol‐Related Liver Disease

  2025cites this paper
• Gegen Huazhuo Tang (GHT) inhibits 7-KDCA and increases TGR5 to promote white fat browning.

  2025cites this paper
• MASLD development: From molecular pathogenesis toward therapeutic strategies

  2025cites this paper
• Epigallocatechin-3-gallate supplementation regulates glucose redistribution through its potential endogenous receptor in grass carp (Ctenopharyngodon idella)

  2025cites this paper
• Role of gut microbiota in the pathogenesis of metabolic syndrome: an updated comprehensive review from mechanisms to clinical implications

  2025cites this paper
• The farnesoid X receptor (FXR) antagonist 7β-isopropylchenodeoxycholic acid improves glucose metabolism in mice on a Western diet.

  2025cites this paper
• GPCR Biased Signaling in Metabolism.

  2025cites this paper
• Plasma and fecal bile acids profiles in metabolic dysfunction-associated steatotic liver disease with advanced fibrosis.

  2025cites this paper
• Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver Disorders

  2025influential citation
• Primary-Secondary-Tertiary Axis of Bile Acid Metabolism in Healthy Subjects.

  2025cites this paper
• The therapeutic effects of dendrobium officinale polysaccharides on diabetes mellitus: from the perspective of gut microbiota

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease: Pathogenesis, model and treatment (Review)

  2025cites this paper
• Protective effects of Polygonum cuspidatum bioactive constituents against cholestatic liver injury: A mechanistic review.

  2025cites this paper
• Relationship of Fat Deposition in the Liver and Pancreas with Cholecystectomy

  2025influential citation
• The Gut Microbiota–Metabolic Axis: Emerging Insights from Human and Experimental Studies on Type 2 Diabetes Mellitus—A Narrative Review

  2025cites this paper
• The Gut‒Liver Axis in Liver Disease: Molecular Mechanisms and Therapeutic Targets

  2025cites this paper
• Cholesterol metabolism regulates macrophage function and inflammation-related diseases.

  2025cites this paper
• Recent advances in the modulatory effects and mechanisms of food-derived polysaccharides on hepatic lipid metabolic dysfunction.

  2025cites this paper
• Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies

  2025cites this paper